Clinical Trials
6 trialsNCT05745740 2023-11-27
A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation
RemeGen Co., Ltd.
Phase 1/2 Unknown
NCT03772353 2023-03-07
PLEASURABLE
Fudan University
Phase 1/2 Unknown
NCT04582968 2023-01-18
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Fudan University
Phase 1/2 Unknown
NCT03805399 2022-08-10
FUTURE
Fudan University
Phase 1/2 Unknown
NCT04227041 2020-01-14
A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Qingdao Zhixin Health Technology Co., Ltd.
Phase 1/2 Unknown
NCT02422199 2018-07-09
A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown